Dr. Anthony Saporita, Senior Scientist for MilliporeSigma, discusses his work on immunoassay development for the interrogation of established and emerging biomarkers for Alzheimer's disease in biological samples. Explaining how the use of multiplex technology can be a powerful tool for discovering biologically interesting patterns in normal or diseased samples.